English
This article is from Frontiers in Neuroendocrinology , volume 35 . Abstract •Biological sex differences are found in the nigrostriatal dopaminergic pathway.•These may underpin the greater male susceptibility to develop Parkinson’s disease.•Female gonadal factors (estradiol) provide resilience to dopamine loss.•Male gonadal factors (testosterone/estradiol) fail to protect/worsen dopamine loss.•Sex-specific hormone-based therapies hold promise for novel treatments.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Sex differences in Parkinson's disease. · Gillies, Glenda E., Pienaar, Ilse S., Vohra, Shiv, Qamhawi, Zahi · Internet Archive